Illustrative image – not actual.Granules India is planning to set up
two new active pharmaceutical ingredients (API) plants in Andhra Pradesh. The project is likely to be financed by
private placement of equity.
The company is also planning to
float a subsidiary in UK or Germany; in addition to its existing wholly-owned
subsidiary in USA.
The proposed API units would have a
combined capacity of around 6,000 tpa. The company already has two API units at
Bonthapally (2,760 tpa) and Jeedimetla (2,376 tpa) in Andhra Pradesh.
The company has recently set up a
7,200 tonne per annum PFI (pharmaceutical formulation intermediates) facility
at an investment of around Rs 30 crore at Gagillapur.
